Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125615822 | 12561582 | 2 | F | 2016 | 20160715 | 20160715 | 20160721 | EXP | DE-BIOGEN-2016BI00263615 | BIOGEN | 41.82 | YR | F | Y | 0.00000 | 20160721 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125615822 | 12561582 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | /wk | |||||||
| 125615822 | 12561582 | 2 | C | FAMPYRA | DALFAMPRIDINE | 1 | Oral | 0 | 10 | MG | UNKNOWN | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125615822 | 12561582 | 1 | Multiple sclerosis |
| 125615822 | 12561582 | 2 | Gait disturbance |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125615822 | 12561582 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125615822 | 12561582 | Accidental exposure to product | |
| 125615822 | 12561582 | Asthenia | |
| 125615822 | 12561582 | Dizziness | |
| 125615822 | 12561582 | Insulinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125615822 | 12561582 | 1 | 20121201 | 0 | ||
| 125615822 | 12561582 | 2 | 20121118 | 0 |